00000nam 2200000zi 4500 9.897250 CaOODSP 20221107174535 m o d f cr cn||||||||| 201005s2020 onca obs f000 0 eng d CaOODSP eng rda CaOODSP n-cn--- H82-52/2020E-PDF PMPRB guidelines. Patented Medicine Prices Review Board guidelines Ottawa, ON : Patented Medicine Prices Review Board = Conseil d'examen du prix des médicaments brevetés, [2020] 1 online resource (39 pages) text txt rdacontent computer c rdamedia online resource cr rdacarrier Issued also in French under title: Lignes directrice du CEPMB. Issued also in HTML format. Includes bibliographical references. "The Guidelines provide information on the PMPRB’s general approach to the price review process and investigations. They supersede all previous guidance documents, policy communiqués and written or verbal statements of any kind by the PMPRB regarding the administration of the price review process and investigations, including all previous versions of the PMPRB’s Compendium of Guidelines, Policies and Procedures."--II, Interpretation, page 3. Drugs Prices Government policy Canada. Canada. Patented Medicine Prices Review Board, issuing body. Lignes directrice du CEPMB. (CaOODSP)9.897251 PDF 513 KB https://publications.gc.ca/collections/collection_2021/cepmb-pmprb/H82-52-2020-eng.pdf HTML N/A https://www.canada.ca/en/patented-medicine-prices-review/services/legislation/about-guidelines/guidelines.html